Literature DB >> 32476898

Seven patients with cryptogenic organizing pneumonia succesfully treated with clarithromycin.

Fatma Ciftci1, Özlem Özdemir Kumbasar1.   

Abstract

Cryptogenic organizing pneumonia is a type of idiopathic interstitial pneumonia with a subacute presentation characterized by variable degrees of cough and dyspnea. As a consequence of the upregulation of inflammatory mediators in cryptogenic organizing pneumonia, it typically responds to anti-inflammatory therapy. Although the majority of patients recover completely with long term oral corticosteroids, relapse is common and their long term use is associated with many adverse effects. Macrolides antiinflammatory agents that appear effective and safe for the treatment of cryptogenic organizing pneumonia. Herein, we analyzed the clinical properties of seven cryptogenic organizing pneumonia patients without severe functional loss who were treated with clarithromycin. (Sarcoidosis Vasc Diffuse Lung Dis 2018; 35: 165-170). Copyright:
© 2018.

Entities:  

Keywords:  COP; COP treatment; clarithromycin; cryptogenic organizing pneumonia; macrolide

Year:  2018        PMID: 32476898      PMCID: PMC7170085          DOI: 10.36141/svdld.v35i2.6887

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  17 in total

1.  Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients.

Authors:  T Johkoh; N L Müller; Y Cartier; P V Kavanagh; T E Hartman; M Akira; K Ichikado; M Ando; H Nakamura
Journal:  Radiology       Date:  1999-05       Impact factor: 11.105

2.  Successful salvage treatment of steroid-refractory bronchiolar COP with low-dose macrolides.

Authors:  Won Jin Chang; Eun Joo Lee; Sang Yeub Lee; Kwang Ho In; Chul Hwan Kim; Han-Kyeom Kim; Sanghoon Park
Journal:  Pathol Int       Date:  2011-11-30       Impact factor: 2.534

Review 3.  Cryptogenic organising pneumonia.

Authors:  J-F Cordier
Journal:  Eur Respir J       Date:  2006-08       Impact factor: 16.671

4.  Idiopathic bronchiolitis obliterans organizing pneumonia/cryptogenic organizing pneumonia with unfavorable outcome: pathologic predictors.

Authors:  S A Yousem; R H Lohr; T V Colby
Journal:  Mod Pathol       Date:  1997-09       Impact factor: 7.842

5.  Macrolides: a treatment alternative for bronchiolitis obliterans organizing pneumonia?

Authors:  Diane E Stover; Debra Mangino
Journal:  Chest       Date:  2005-11       Impact factor: 9.410

6.  Cryptogenic Organizing Pneumonia: IL-1β, IL-6, IL-8, and TGF- β1 Serum Concentrations and Response to Clarithromycin Treatment.

Authors:  E Radzikowska; A Roży; P Jaguś; E Wiatr; D Gawryluk; J Chorostowska-Wynimko; K Roszkowski-Śliż
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

7.  Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells.

Authors:  T Ichiyama; M Nishikawa; T Yoshitomi; S Hasegawa; T Matsubara; T Hayashi; S Furukawa
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

8.  Anti-inflammatory activity of macrolide antibiotics.

Authors:  A Ianaro; A Ialenti; P Maffia; L Sautebin; L Rombolà; R Carnuccio; T Iuvone; F D'Acquisto; M Di Rosa
Journal:  J Pharmacol Exp Ther       Date:  2000-01       Impact factor: 4.030

Review 9.  Acute and subacute idiopathic interstitial pneumonias.

Authors:  Hiroyuki Taniguchi; Yasuhiro Kondoh
Journal:  Respirology       Date:  2016-04-28       Impact factor: 6.424

10.  Bronchiolitis obliterans organizing pneumonia. Clinical features and differential diagnosis.

Authors:  T Izumi; M Kitaichi; K Nishimura; S Nagai
Journal:  Chest       Date:  1992-09       Impact factor: 9.410

View more
  1 in total

1.  Transthoracic Ultrasound in Infectious Organizing Pneumonia: A Useful Guide for Percutaneous Needle Biopsy.

Authors:  Donato Lacedonia; Carla Maria Irene Quarato; Cristina Borelli; Lucia Dimitri; Paolo Graziano; Maria Pia Foschino Barbaro; Giulia Scioscia; Antonio Mirijello; Michele Maria Maggi; Gaetano Rea; Beatrice Ferragalli; Salvatore De Cosmo; Marco Sperandeo
Journal:  Front Med (Lausanne)       Date:  2021-07-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.